Golding B - Search Results

1

Treatment of anthrax infection with combination of ciprofloxacin and antibodies to protective antigen of Bacillus anthracis.

Karginov VA, Robinson TM, Riemenschneider J, Golding B, Kennedy M, Shiloach J, Alibek K. Karginov VA, et al. Among authors: golding b. FEMS Immunol Med Microbiol. 2004 Jan 15;40(1):71-4. doi: 10.1016/S0928-8244(03)00302-X. FEMS Immunol Med Microbiol. 2004. PMID: 14734189 Free article.

2

Passive immunotherapy of Bacillus anthracis pulmonary infection in mice with antisera produced by DNA immunization.

Herrmann JE, Wang S, Zhang C, Panchal RG, Bavari S, Lyons CR, Lovchik JA, Golding B, Shiloach J, Lu S. Herrmann JE, et al. Among authors: golding b. Vaccine. 2006 Jul 26;24(31-32):5872-80. doi: 10.1016/j.vaccine.2006.04.065. Epub 2006 May 15. Vaccine. 2006. PMID: 16790303

3

Expression of human alpha1-proteinase inhibitor in Aspergillus niger.

Karnaukhova E, Ophir Y, Trinh L, Dalal N, Punt PJ, Golding B, Shiloach J. Karnaukhova E, et al. Among authors: golding b. Microb Cell Fact. 2007 Oct 29;6:34. doi: 10.1186/1475-2859-6-34. Microb Cell Fact. 2007. PMID: 17967194 Free PMC article.

4

Production, purification, and characterization of human alpha1 proteinase inhibitor from Aspergillus niger.

Chill L, Trinh L, Azadi P, Ishihara M, Sonon R, Karnaukhova E, Ophir Y, Golding B, Shiloach J. Chill L, et al. Among authors: golding b. Biotechnol Bioeng. 2009 Feb 15;102(3):828-44. doi: 10.1002/bit.22099. Biotechnol Bioeng. 2009. PMID: 18828177 Free PMC article.

5

Development and evaluation of an ELISA for quantification of human alpha-1-proteinase inhibitor in complex biological mixtures.

Karnaukhova E, Golding B, Ophir Y. Karnaukhova E, et al. Among authors: golding b. Biologicals. 2007 Oct;35(4):285-95. doi: 10.1016/j.biologicals.2006.11.002. Epub 2007 Jan 24. Biologicals. 2007. PMID: 17257853

6

Recombinant human alpha-1 proteinase inhibitor: towards therapeutic use.

Karnaukhova E, Ophir Y, Golding B. Karnaukhova E, et al. Among authors: golding b. Amino Acids. 2006 Jun;30(4):317-32. doi: 10.1007/s00726-005-0324-4. Epub 2006 May 26. Amino Acids. 2006. PMID: 16773239 Review.

7

Mucosal immunity in mice immunized with HIV-1 peptide conjugated to Brucella abortus.

Golding B, Eller N, Levy L, Beining P, Inman J, Matthews N, Scott DE, Golding H. Golding B, et al. Among authors: golding h. Vaccine. 2002 Jan 31;20(9-10):1445-50. doi: 10.1016/s0264-410x(01)00477-7. Vaccine. 2002. PMID: 11818165

8

Programming of CTL with heat-killed Brucella abortus and antigen allows soluble antigen alone to generate effective secondary CTL.

Inoue S, Golding B, Scott D. Inoue S, et al. Among authors: golding b. Vaccine. 2005 Feb 25;23(14):1730-8. doi: 10.1016/j.vaccine.2004.09.034. Vaccine. 2005. PMID: 15705479

9

Plasma derivatives: new products and new approaches.

Sauna ZE, Pandey GS, Jain N, Mahmood I, Kimchi-Sarfaty C, Golding B. Sauna ZE, et al. Among authors: golding b. Biologicals. 2012 May;40(3):191-5. doi: 10.1016/j.biologicals.2011.11.003. Epub 2012 Jan 11. Biologicals. 2012. PMID: 22239993 Review.

10

Aptamers as a sensitive tool to detect subtle modifications in therapeutic proteins.

Zichel R, Chearwae W, Pandey GS, Golding B, Sauna ZE. Zichel R, et al. Among authors: golding b. PLoS One. 2012;7(2):e31948. doi: 10.1371/journal.pone.0031948. Epub 2012 Feb 27. PLoS One. 2012. PMID: 22384109 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

357 results

Search Page